The effect of MMP-9 ablation should be studied in relation to dysregulated mitophagy during heart failure to determine if it helps with the cardiomyocyte death seen in HFrEF and if it helps preserve ejection fraction transition to reduced ejection fraction. The gene discussed is MMP9; the disease is heart failure.